Ramadan Abdelaziz

Dr. Ramadan Abdelaziz

NA, International Atomic Energy Agency, Vienna, Wien, Austria
orcid
Ramadan.faried86@gmail.com

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2022 in Chemosphere
Verified
Journal Article
Closed access
GHG. Harini
G. Harini
MOMohammad K. Okla
Mohammad K. Okla
IAIbrahim A. Alaraidh
Ibrahim A. Alaraidh
AMAsmaa Mohebaldin
Asmaa Mohebaldin
AAAbdullah A. Al-Ghamdi
Abdullah A. Al-Ghamdi
SKSudheer Khan
Sudheer Khan

Verified
Journal Article
Open access
PDF file
MAMohammed Aufy
Mohammed Aufy
Ramadan AbdelazizRamadan Abdelaziz
Ramadan Abdelaziz
AHAhmed M. Hussein
Ahmed M. Hussein
NTNermina Topcagic
Nermina Topcagic
HSHadil Shamroukh
Hadil Shamroukh
CSChristian R. Studenik
Christian R. Studenik
Enniatin B (ENN B) and Beauvericin (BEA) are cyclohexadepsipeptides that can be isolated from Fusarium and Beauveria bassiana, respectively. Both compounds are cytotoxic and ionophoric. In the present study, the mechanism of cell death induced by these compounds was investigated. Epidermal carcinoma-derived cell line KB-3-1 cells were treated with different concentrations of these compounds. The extracellular secretion of cathepsin B increased in a concentration-dependent manner, and the lysosomal staining by lysotracker red was reduced upon the treatment with any of the compounds. However, the extracellular secretion of cathepsin L and cathepsin D were not affected. Inhibition of cathepsin B with specific inhibitor CA074 significantly reduced the cytotoxic effect of both compounds, while inhibition of cathepsin D or cathepsin L did not influence the cytotoxic activities of both compounds. In vitro labelling of lysosomal cysteine cathepsins with Ethyl (2S, 3S)-epoxysuccinate-Leu-Tyr-Acp-Lys (Biotin)-NH2 (DCG04) was not affected in case of cathepsin L upon the treatment with both compounds, while it was significantly reduced in case of cathepsin B. In conclusion, ENN B and BEA increase lysosomal Ph, which inhibits delivery of cathepsin B from Golgi to lysosomes, thereby inducing cathepsin B release in cytosol, which activates caspases and hence the apoptotic pathway.

19 July 2022 in Journal of Environmental Management
Verified
Journal Article
Closed access
SBS. Balasurya
S. Balasurya
MOMohammad K. Okla
Mohammad K. Okla
IAIbrahim A. Alaraidh
Ibrahim A. Alaraidh
AAAbdullah A. Al-Ghamdi
Abdullah A. Al-Ghamdi
AMAsmaa Mohebaldin
Asmaa Mohebaldin
SKSudheer Khan
Sudheer Khan

30 April 2022 in Chemosphere
Verified
Journal Article
Closed access
VSV. Subhiksha
V. Subhiksha
MOMohammad K. Okla
Mohammad K. Okla
IAIbrahim A. Alaraidh
Ibrahim A. Alaraidh
AMAsmaa Mohebaldin
Asmaa Mohebaldin
WSWalid Soufan
Walid Soufan
SKSudheer Khan
Sudheer Khan

Verified
Journal Article
Open access
PDF file
Ramadan AbdelazizRamadan Abdelaziz
Ramadan Abdelaziz
AHAhmed M. Hussein
Ahmed M. Hussein
MKMohamed H. KOTOB
Mohamed H. KOTOB
CWChristina Weiss
Christina Weiss
KCKrzysztof Chelminski
Krzysztof Chelminski
MAMohammed Aufy
Mohammed Aufy
Cancer is one of the main causes of death globally. Radiotherapy/Radiation therapy (RT) is one of the most common and effective cancer treatments. RT utilizes high-energy radiation to damage the DNA of cancer cells, leading to their death or impairing their proliferation. However, radiation resistance remains a significant challenge in cancer treatment, limiting its efficacy. Emerging evidence suggests that cathepsin L (cath L) contributes to radiation resistance through multiple mechanisms. In this study, we investigated the role of cath L, a member of the cysteine cathepsins (caths) in radiation sensitivity, and the potential reduction in radiation resistance by using the specific cath L inhibitor (Z-FY(tBu)DMK) or by knocking out cath L with CRISPR/Cas9 in colon carcinoma cells (caco-2). Cells were treated with different doses of radiation (2, 4, 6, 8, and 10), dose rate 3 Gy/min. In addition, the study conducted protein expression analysis by western blot and immunofluorescence assay, cytotoxicity MTT, and apoptosis assays. The results demonstrated that cath L was upregulated in response to radiation treatment, compared to non-irradiated cells. In addition, inhibiting or knocking out cath L led to increased radiosensitivity in contrast to the negative control group. This may indicate a reduced ability of cancer cells to recover from radiation-induced DNA damage, resulting in enhanced cell death. These findings highlight the possibility of targeting cath L as a therapeutic strategy to enhance the effectiveness of RT. Further studies are needed to elucidate the underlying molecular mechanisms and to assess the translational implications of cath L knockout in clinical settings. Ultimately, these findings may contribute to the development of novel treatment approaches for improving outcomes of RT in cancer patients.

Verified
Journal Article
Open access
PDF file
Ramadan AbdelazizRamadan Abdelaziz
Ramadan Abdelaziz
AHAhmed M. Hussein
Ahmed M. Hussein
MKMohamed H. KOTOB
Mohamed H. KOTOB
CWChristina Weiss
Christina Weiss
KCKrzysztof Chelminski
Krzysztof Chelminski
MAMohammed Aufy
Mohammed Aufy
Cathepsins (Caths) are lysosomal proteases that participate in various physiological and pathological processes. Accumulating evidence suggests that caths play a multifaceted role in cancer progression and radiotherapy resistance responses. Their proteolytic activity influences the tumor’s response to radiation by affecting oxygenation, nutrient availability, and immune cell infiltration within the tumor microenvironment. Cathepsin-mediated DNA repair mechanisms can promote radioresistance in cancer cells, limiting the efficacy of radiotherapy. Additionally, caths have been associated with the activation of prosurvival signaling pathways, such as PI3K/Akt and NF-κB, which can confer resistance to radiation-induced cell death. However, the effectiveness of radiotherapy can be limited by intrinsic or acquired resistance mechanisms in cancer cells. In this study, the regulation and expression of cathepsin B (cath B) in the colon carcinoma cell line (caco-2) before and after exposure to radiation were investigated. Cells were exposed to escalating ionizing radiation doses (2 Gy, 4 Gy, 6 Gy, 8 Gy, and 10 Gy). Analysis of protein expression, in vitro labeling using activity-based probes DCG04, and cath B pull-down revealed a radiation-induced up-regulation of cathepsin B in a dose-independent manner. Proteolytic inhibition of cathepsin B by cathepsin B specific inhibitor CA074 has increased the cytotoxic effect and cell death due to ionizing irradiation treatment in caco-2 cells. Similar results were also obtained after cathepsin B knockout by CRISPR CAS9. Furthermore, upon exposure to radiation treatment, the inhibition of cath B led to a significant upregulation in the expression of the proapoptotic protein BAX, while it induced a significant reduction in the expression of the antiapoptotic protein BCL-2. These results showed that cathepsin B could contribute to ionizing radiation resistance, and the abolishment of cathepsin B, either by inhibition of its proteolytic activity or expression, has increased the caco-2 cells susceptibility to ionizing irradiation.